Sandbox cerebral palsy: Difference between revisions

Jump to navigation Jump to search
Aditya Ganti (talk | contribs)
Aditya Ganti (talk | contribs)
 
(56 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==Causes==
===Pathophysiology===
Birth asphyxia is believed to be the principal etiology for cerebral palsy. However, recent studies demonstrated that 70% to 80% of cases of cerebral palsy are due to antenatal factors, while only 10% to 28% of cases are due to birth asphyxia in term and near-term infants. Causes of cerebral palsy are often multifactorial. For example, an intrauterine infection may result in growth restriction, maternal fever, and prematurity, all of which have been associated with cerebral palsy.
====Mucosal barrier====
===Prenatal causes===
*The gastric mucosa is protected from the acidic environment by mucus, bicarbonate, prostaglandins, and blood flow.
*Placental insufficiency
*This mucosal barrier consists of three protective components which include:
*Intrauterine infection
**Layer of epithelial cells lining.  
*Chromosomal abnormalities
**Layer of mucus, secreted by surface epithelial cells and Foveolar cells.  
*Maternal illness
**Bicarbonate ions, secreted by the surface epithelial cells.
**Chorioamnionitis
[[Image: Stomach mucosal layer labeled.svg.png|center|]]
**Thyroid disease
**Thrombotic disorders including factor V Leiden mutations
**TORCH infections (toxoplasmosis, syphilis, rubella, cytomegalovirus, varicella zoster, HIV, herpes viruses)
*Multiple births
*Teratogen exposure
*Metabolic disorders
*Fetal brain malformation
===Placental pathology===
*Thrombotic lesions
*Placental ischemia has been associated with spastic diplegia
*Chronic villitis
*Pre-eclampsia
===Perinatal causes===
*Hypoxia-ischemia
*Neonatal encephalopathy
*Periventricular leukomalacia (PVL)
**PVL increases the risk of cerebral palsy, independent of gestational age.
**Approximately 75% of infants with cystic PVL develop cerebral palsy.
*Fetal/neonatal stroke
*Hyperbilirubinemia
*Hemolytic disease
*Kernicterus
===Postnatal causes===
*Stroke
*Trauma
*Infection


===Mechanism of Action===
*The insoluble mucus forms a protective gel-like coating over the entire surface of the gastric mucosa.
*The mucus protects the gastric mucosa from autodigestion by e.g. pepsin and from erosion by acids and other caustic materials that are ingested.
*The bicarbonate ions act to neutralize harsh acids.
*If the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage
===Pathogenesis===
*Regardless of etiology, if the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage.
**Helicobacter pylori disrupts the mucosal barrier and causes inflammation of the mucosa of the stomach and duodenum.
**As the ulcer progresses beyond the mucosa to the submucosa the inflammation causes weakening and necrosis of arterial walls, leading to pseudoaneurysm formation followed by rupture and hemorrhage.
**NSAIDs inhibit cyclooxygenase, leading to impaired mucosal defenses by decreasing mucosal prostaglandin synthesis.
**During stress, there is acid hypersecretion; therefore, the breakdown of mucosal defenses leads to injury of the mucosa and subsequent bleeding.
**Mucosal defects along with dilated and tortuous vessels in dieulafoy lesion put them at risk for rupture because of necrosis of the arterial wall from exposure to gastric acid.
{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | A01 | | | | | |A01=Cerebral palsy}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | |A01=Inflammatory Bowel Disease}}
{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | }}
{{familytree | | C01 | | | | | C02 | | | | | C03 |C01=Antenatal|C02=Perinatal|C03=Postnatal}}
{{familytree | | | | | | | | | | | | | |,|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | }}
{{familytree | | |!| | | | | | |!| | | | | | |!| }}
{{familytree | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | B02 |B01=Crohn's Disease|B02=Ulcerative colitis}}
{{familytree | | D01 | | | | | D02 | | | | | D03 |D01=Prematurity and low birth weight <br> Intrauterine infections<br>Multiple gestations<br> Pregnancy complications|D02=Birth Asphyxia<br> complicated labour and delivery |D03=Head trauma<br>Meningitis<br>Cardio-pulmonary arrest}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| | | | | | | | | |!|}}
{{familytree | | | | | | | Z01 | | | | | | | | | | Z02 | | | | | | | | |!| |Z01=Based on Region involved|Z02=Based on Severity}}
{{familytree | | | |,|-|-|-|+|-|-|-|.| | | |,|-|-|-|+|-|-|-|.| | | | | |!| | }}
{{familytree | | | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | | | | |!| |C01=Ileocolic Crohn's disease|C02=Crohn's ileitis|C03=Crohn's colitis|C04=Stricturing disease|C05=Penetrating disease|C06=Inflammatory disease}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |,|-|-|-|-|-|^|-|-|-|.| | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | Z01 | | | | | | | | Z02 | |Z01=Based on Region involved|Z02=Based on Severity}}
{{familytree | | | | | | | | | | | | | | | | | | | |,|-|-|-|^|-|.| | | |,|-|-|-|+|-|-|-|v|-|-|-|.| }}
{{familytree | | | | | | | | | | | | | | | | | | | C01 | | | | C02 | | C03 | | C04 | | C05 | | C06 | C01=Distal UC|C02=Proximal UC|C03=Mild|C04=Moderate|C05=Severe|C06=Flumiant|}}  
{{familytree/end}}
{{familytree/end}}


In 2004 the International Executive Committee for the Definition of Cerebral Palsy revised the definition of cerebral palsy and described Cerebral palsy (CP) as a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy often are accompanied by disturbances of sensation, perception, cognition, communication, and behavior, by epilepsy, and by secondary musculoskeletal problems.
==Pathophysiology==
Cerebral palsy is a heterogeneous disorder of movement and posture that has a wide variety of presentations, ranging from mild motor disturbance to severe total body involvement. Because of this variability in clinical presentation and the absence of a definitive diagnostic test, defining exactly what cerebral palsy is has been difficult and controversial. It is generally agreed that there are three distinctive features common to all patients with cerebral palsy:
*Some degree of motor impairment, which distinguishes it from other conditions, such as global developmental delay or autism
*An insult to the developing brain, making it different from conditions that affect the mature brain in older children and adults
*A neurologic deficit that is nonprogressive, which distinguishes it from other motor diseases of childhood, such as the muscular dystrophies.
===Initial Insult===
*The premature neonatal brain is susceptible to two main pathologies intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL).
*Although both pathologies increase the risk of cerebral palsy, periventricular leukomalacia is more closely related to cerebral palsy and is the leading cause in preterm infants.
*Both IVH and PVL cause CP because the corticospinal tracts, composed of descending motor axons, course through the periventricular region.
*The insult to the brain is believed to occur between the time of conception and age 2 years, at which time a significant amount of motor development has occurred.
*A similar injury to the brain after age 2 years can have a similar effect, however, and often is results in classic picture of cerebral palsy.
*By 8 years of age, most of the development of the immature brain is complete, as is gait development, and an insult to the brain results in a more adult-type clinical picture and outcome.
Major events in human brain development and their peak times of occurrence include the following:
Primary neurulation – Weeks 3-4 of gestation
Prosencephalic development – Months 2-3 of gestation
Neuronal proliferation – Months 3-4 of gestation
Neuronal migration – Months 3-5 of gestation
Organization – Month 5 of gestation to years postnatal
Myelination – Birth to years postnatal


===Disease progression===
{{familytree/start}}
*Although the neurologic deficit is permanent and nonprogressive, the effect it can have on the patient is dynamic, and the orthopaedic aspects of cerebral palsy can change dramatically with growth and development.
{{familytree | | | | | | | | | | | | | | | A01 | | | | | | | | | | | |A01=A01}}
*Growth, along with altered muscle forces across joints, can lead to progressive loss of motion, contracture, and eventually joint subluxation or dislocation, resulting in degeneration that may require orthopaedic intervention.
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | |}}
*Children with cerebral palsy constitute the largest group of pediatric patients with neuromuscular disorders in the United States. The prevalence of cerebral palsy varies around the world according to the amount and quality of prenatal care, the socioeconomic condition of the parents, the environment, and the type of obstetric and pediatric care the mother and child receive. The determination of the true prevalence also is difficult because many children are not diagnosed until age 2 or 3 years; this most often occurs in socioeconomic groups that have decreased access to medical care. In the United States, the occurrence is approximately two per 1000 live births; there are approximately 25,000 new patients with cerebral palsy each year, and approximately 400,000 children with cerebral palsy at any given time. The United States experienced an initial decrease in the number of affected children in the 1950s and 1960s as a result of better understanding and treatment of maternal-fetal Rh incompatibility and improvements in obstetric techniques. More recently, the prevalence of cerebral palsy was thought to be increasing because of the increased survival of premature and low-birth-weight infants; however, two large population-based studies showed that the improved survival of these infants has not contributed to the increase in prevalence of cerebral palsy in the United States. Worldwide, the prevalence ranges from 0.6 to 7.0 cases per 1000 live births. The cost of operative treatment in children with cerebral palsy is substantial. In 1997, there were an estimated 37,000 operative procedures performed, with the most common being gastrostomy tube placements, soft-tissue releases, fundoplications, spinal fusions, and hip osteotomies. These procedures accounted for 50,000 hospital days and $150 million in charges.
{{familytree | | | | | | | | | | | | | | | B01 | | | | | | | | | | | |B01=B01}}
{{familytree | | | | | | | | | | | | | | | |!| | | | | | | | | | | | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | }}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | | |!| | | | | | | }}
{{familytree | | | | | | C01 | | | | | | | | | | | | | | | C02 | | | | | | |C01=C01|C02=C02}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | D01 | | | | | | |D01=D01}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | E01 | | | | | | |E01=E01}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | F01 | | | | | | |F01=F01}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | G01 | | | | | | |G01=G01}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | |,|-|-|-|-|-|^|-|-|-|-|-|-|.|}}
{{familytree | | | | | | | | | | | | | | | | | H01 | | | | | | | | | | | H02 | |H01=H01|H02=H02}}
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | | | | | | | | | | I01 | | | | | | | | | | | I02 | | |I01=I01|I02=I02}}
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | J01 | | | | | | | | | | | | | | |J01=J01}}
{{familytree/end}}
 
==Pathogenesis of Crohn's disease==
*Genetic component
*Stress and environmental component
*Microbial component
*Inflammatory component
===Genetic Component===
====Genes involved====
*NOD2/CARD15 gene
*OCTN1 gene
*DLG5 gene
*TLR4 gene


Injury to the developing brain can occur at any time from gestation to early childhood and typically is categorized as prenatal, perinatal, or postnatal. Contrary to popular belief, fewer than 10% of injuries that result in cerebral palsy occur during the birth process, with most occurring in the prenatal period. A wide variety of risk factors for cerebral palsy have been identified in the prenatal period, including risk factors inherent to the fetus (most commonly genetic disorders), factors inherent to the mother (seizure disorders, mental retardation, and previous pregnancy loss), and factors inherent to the pregnancy itself (Rh incompatibility, polyhydramnios, placental rupture, and drug or alcohol exposure). External factors, such as TORCH syndrome (toxoplasmosis, other agents, rubella, cytomegalovirus, herpes simplex), also can lead to cerebral palsy in the prenatal period. Occurrences in the absence of any known risk factors may be caused by some yet unknown factor during this critical time in brain development. Several more recent studies have suggested a possible role of chorioamnionitis as one of these factors.
{| class="wikitable"
!Genes
! colspan="2" |Chromosome
!Function
!Mutation
|-
|NOD2/CARD15
|16
|16q12.1
|Encodes a scaffolding protein important for maintaining epithelial integrity
|Disrupts normal epithelial integrity
|-
|OCTN1
|05
|5q31
|Ecodes an ion channel
|Alters the function of cation transporters and cell-to-cell signaling
|-
|DLG5
|10
|10q22.3
|Interact additively with the NOD2/CARD15 gene
|Iincrease susceptibility to CD along with CARD15
|-
|TLR4
|09
|9q33.1
|Lipopolysaccharide signaling, bacterial recognition, and subsequent immune response
|Altered immune response to pathogens and a subsequent increase in inflammation.
|}
===Stress and Environmental Component===
*Stress signals are perceived by the central nervous system (CNS), triggering the hypothalamic-pituitary-adrenal axis and the sympathetic-adrenal-medullary axis.
*Neuroendocrine mediators released in response to stress not only modulate secretory, absorptive, and barrier functions in the gut but also increase the gut permeability.
*Stress increases gut permeability along with other factors which inlude
**Corticotropin-releasing factor
**Autonomic nervous system
**Enteric nervous system


Cerebral palsy in the perinatal period, from birth until a few days after birth, typically is associated with asphyxia or trauma that occurs during labor. Oxytocin augmentation, umbilical cord prolapse, and breech presentation all have been associated with an increased occurrence of cerebral palsy. Only 10% of cases of cerebral palsy occur during this time period, and most patients with cerebral palsy have no history of asphyxia. Although cerebral palsy is often associated with low Apgar scores during this period, many neonates have low scores because of other conditions, such as genetic disorders, that are completely unrelated to asphyxia. Low-birth-weight infants (<1500 g) are at dramatically increased risk of cerebral palsy, with an incidence of 60 per 1000 births compared with two per 1000 births in infants of normal weight. This increased incidence is believed to be caused by the fragility of the periventricular blood vessels, which are highly susceptible to physiologic fluctuations during pregnancy ( Fig. 33-1 ). These fluctuations, which include hypoxic episodes, placental pathology, maternal diabetes, and infection, can injure these vessels and lead to subsequent intraventricular hemorrhages. These injuries are graded on a scale from I to IV ( Table 33-1 ), with an increased incidence of neurologic consequences such as hydrocephalus and cerebral palsy in grade III (bleeding into ventricles with dilation) and grade IV (bleeding into brain substance). In addition, the periventricular area, which is important for motor control, is especially susceptible from the 26th to the 32nd week of pregnancy. If this area is injured, diplegia usually results. Often, a synergistic combination of events leads to brain injury and the subsequent development of cerebral palsy. Pregnancies involving multiple births also are at increased risk for cerebral palsy, primarily because of their association with premature delivery.
===Microbial Component===
The possible mechanisms for a bacterial etiology in the development of CD include:
*Initial immune response to a specific pathogen resulting in intestinal infection
*Alterations in normal bacterial flora of the intestinal tract
*Defective mucosal barrier and overwhelming exposure to resident bacteria and their antigens and endotoxins
*Alterations to the intestinal immune response


==Classification==
{| border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
The Manual Ability Classification System (MACS) describes how children with cerebral palsy (CP) use their hands to handle objects in daily activities. MACS describes five
! style="background:#efefef;" |Infectious Pathogens Implicated in Crohn’s Disease
levels. The levels are based on the children’s self-initiated ability to handle objects and their need for assistance or adaptation to perform manual activities in everyday life.
|-
|
*Escherichia coli<br>
*Listeria monocytogenes<br>
*Yersinia enterocolitica<br>
*Mycobacterium avium subspecies paratuberculosis<br>
*Measles virus
|}


{{familytree/start |summary=Sample 1}}
=== Immune Component ===
{{familytree | | | | | | | | A01 |A01=Does the child handle most kind of<br> daily activities independently<br>( during play and leisure, eating and dressing)}}  
*'''<u>Altered immune response</u>''':
{{familytree | | | | |,|-|-|-|^|-|-|-|-|-|.| | | }}
** An abnormal antibody response to an unspecified bacterial antigen is mainly responsible for inflammation in Crohn's disease.
{{familytree | | | B01 | | | | | | | | | B02 | | |B01='''Yes'''|B02='''No'''}}
** The inflammatory response is believed to be triggered when elimination of specified microbial antigen was unsuccessful leading to altered immune response
{{familytree | | | |!| | | | | | | | | | |!| }}
** Dysregulation of normal mucosal immune response results in failure of phagocytosis leading to antigen persistence.
{{familytree | | | C01 | | | | | | | | | C02 |C01=Does the child handle even more difficult tasks<br> with fair speed and accuracy and<br> does not need alternative ways to perform| C02=Does the child perform number of mannual tasks<br>which commonly need to prepared or adapted <br> and help is needed occasionally|}}
** Antigen persistance leads to antibodies production against all the normal gut flora.
{{familytree | |,|-|^|-|.| | | | | |,|-|-|^|-|.| }}
** Activation resulted in secretion of tumor necrosis factor-alpha (TNF-alpha) and subsequent epithelial changes.
{{familytree | D01 | | D02 | | | | D03 | | | D04 |D01='''Yes'''|D02='''No'''|D03='''Yes'''|D04='''No'''|}}
*'''<u>Cytokine response</u>''':
{{familytree | |!| | | |!| | | | | |!| | | | |!| }}
**The primary precipitating event in Crohn's disease is T-cell  mediated immune response.
{{familytree | E01 | | E02 | | | | E03 | | | E04 |E01='''Level 1'''<br>Handles objects easily and successfully|E02='''Level 2'''<br>Handles most objects with <br> reduced quality and speed of acheivement|E03='''Level 3'''<br>Handles objects with <br> difficulty but needs preparation|E04=Can the child perform<br>easy activites with frequent support |}}
**Activated T cells are responsible for the release of cytokines.
{{familytree | | | | | | | | | | | | | |,|-|-|^|-|-|.| | }}
**The production of inflammatory cytokines results in ulceration and increased intestinal permeability.
{{familytree | | | | | | | | | | | | | F01 | | | | F02 |F01='''Yes'''|F02='''No'''}}
**The characteristic granulomatous lesion seen in Crohn’s disease is evidence of a cell-mediated immune response.
{{familytree | | | | | | | | | | | | | |!| | | | | |!| |}}
**The early lesions of Crohn's disease are characterized by elevations in interleukin-4 (IL-4) and decrease in IFN-gamma, a pattern more consistent with an overactive Th2 immune response.
{{familytree | | | | | | | | | | | | | G01 | | | | G02 |G01='''Level 4'''<br>Handles easy activites <br> with limitations and support|G02='''Level 5'''<br>Cannot handle daily activites <br> has severely limited abilities to perform even simple actions }}
**Chronic lesions are associated with high levels of interleukin-2 (IL-2), interferon gamma (IFN-gamma), TNF-alpha, and interleukin-12 and -18 (IL-12 and IL-18) consistent with an Th1 immune response.
**Tumor necrosis factor appears to play a significant role in the pathogenesis of CD.
***TNF-alpha induces expression of adhesion factors that allow for inflammatory cells to infiltrate and activates macrophages to promote release of other pro-inflammatory mediators such as IFN-gamma.
***Neutralization of TNF resulted in significant decrease in inflammation.
***TNF-alpha concentrations in the stool can be used to monitor disease activity in both CD and UC.
==Oxidative stress==
*Oxidative stress also plays a significant role in the pathogenesis of Crohn's disease.
 
*Endogenous antioxidants such as superoxide dismutase (SOD), glutathione, and catalase normally counteract oxidative stress in the intestinal mucosa.
*However, during the times of inflammation the demand for these antioxidants is increased resulting in an imbalance between oxidants and antioxidants, with subsequent mucosal damage.
*Oxidative DNA damage can be measured from the amount of 8-hydroxy-deoxy-guanosine (8-OhdG) present in blood.
*Levels of 8-OhdG are higher in patients with Crohn's disease.
*Oxidative stress can also activate nuclear factor-kappaB (NF-kappaB) gene leading to release of TNF-alpha and interleukins involved in inflammation.
 
== Other factors responsible for Pathogenesis of Crohn's disease ==
 
===== Platelet Abnormalities =====
* Increased platelet count is a common feature of active Crohn’s disease and contributes to the increased incidence of thromboembolism seen in both CD and UC.
* In addition to increased platelet count, CD is characterized by increased platelet activation in the mesenteric vessels.
* Although platelet function has historically been considered to involve primarily blood clotting, there is considerable evidence for platelet involvement in inflammation.
* Platelets from inflammatory bowel-diseased tissues have been found to express a number of inflammatory mediators, including CD40 L, a substance similar to tumor necrosis factor that directs platelets toward inflammation instead of aggregation.
* A sequence of events has been postulated in which platelets trigger chemokine-mediated adhesion of white blood cells to the endothelium, causing leukocyte migration and subsequent focal inflammatory lesions.
 
===== Mitochondrial Dysfunction =====
* TNF alpha enhances mitochondrial NF-kappa B expression, down-regulating mitochondrial RNA expression.
* Resulting in impaired oxidative phosphorylation,with abnormalities in complexes III and IV.
 
===== Elevated Homocysteine =====
* Vitamin B12 is essential for the metabolism of homo-cysteine to cysteine, taurine, sulfate, and glutathione.
* Conditions that result in vit-B6 deficiency can lead to an increased levels of homo-cysteine levels.
 
* Higher levels of homo-cysteine levels are associated with hypocoagulation states and subsequent thrombosis.
* Therefore Crohn's patients are at risk for thrombo-embolism due to high homo-cysteine levels.
 
==The Lactulose-Mannitol Test for Small Intestinal Hyperpermeability==
*Patient is made to swallows a solution of 5 g mannitol and 5 g lactulose.
*Urine sample is collected for six hours.
*Assay for total lactulose and mannitol
**< 14% mannitol = carbohydrate malabsorption
**>1% lactulose = disaccharide hyperpermeability
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | |A01=A01 }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | |}}
{{familytree | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | B02 | | | |B01=B01|B02=B02}}
{{familytree | | | | |,|-|-|-|v|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|.| | | |!| | | | | }}
{{familytree | | | | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | | C07 | | |!| | | | |C01=C01|C02=C02|C03=C03|C04=C04|C05=C05|C06=C06|C07=C07}}
{{familytree | | | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | | |}}
{{familytree | | | | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | | C07 | | |!| | | | |C01=C01|C02=C02|C03=C03|C04=C04|C05=C05|C06=C06|C07=C07}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.|}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | B01 | | | | | | | | B02 |B01=B01|B02=B02}}  
{{familytree/end}}
{{familytree/end}}




{{familytree/start}}
{{familytree | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | |B01=B01|B02=B02}}
{{familytree | | | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|-|.| | | | | | | | | }}
{{familytree | | | | C01 | | | | | | | | | | C04 | | | | | | | | | | C07 | | | | | | | |C01=C01|C04=C04|C07=C07}}
{{familytree | | | | | | | | | | | | | | | | |!| | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | C01 | | | | | | | | | | C04 | | | | | | | | | | C07 | | | | | | | |C01=C01|C04=C04|C07=C07}}
{{familytree/end}}




{{familytree/start}}
{{familytree/start}}
{{familytree | | | | | | | | | A01 | | | | | |A01=A01}}
{{familytree | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | |B01=B01}}
{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }}
{{familytree | | | | | | | | | | | | |,|-|-|-|+|-|-|-|.| | | | | | | | | | | | | | | | | }}
{{familytree | | C01 | | | | | C02 | | | | | C03 |C01=C01|C02=C02|C03=C03}}
{{familytree | | | | | | | | | | | | C03 | | C04 | | C05 | | | | |C03=C03|C04=C04|C05=C05|}}
{{familytree | | |!| | | | | | |!| | | | | | |!| }}
{{familytree | | | | | | | | | | | | |!| | | |!| | | |!| | | | | | | | | | | | | | | | |}}
{{familytree | | D01 | | | | | D02 | | | | | D03 |D01=D01|D02=D02|D03=D03}}
{{familytree | | | | | | | | | | | | C03 | | C04 | | C05 | | | | | | | | | | | |C03=C03|C04=C04|C05=C05|}}
{{familytree/end}}
{{familytree/end}}

Latest revision as of 23:49, 3 February 2018

Pathophysiology

Mucosal barrier

  • The gastric mucosa is protected from the acidic environment by mucus, bicarbonate, prostaglandins, and blood flow.
  • This mucosal barrier consists of three protective components which include:
    • Layer of epithelial cells lining.
    • Layer of mucus, secreted by surface epithelial cells and Foveolar cells.
    • Bicarbonate ions, secreted by the surface epithelial cells.

Mechanism of Action

  • The insoluble mucus forms a protective gel-like coating over the entire surface of the gastric mucosa.
  • The mucus protects the gastric mucosa from autodigestion by e.g. pepsin and from erosion by acids and other caustic materials that are ingested.
  • The bicarbonate ions act to neutralize harsh acids.
  • If the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage

Pathogenesis

  • Regardless of etiology, if the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage.
    • Helicobacter pylori disrupts the mucosal barrier and causes inflammation of the mucosa of the stomach and duodenum.
    • As the ulcer progresses beyond the mucosa to the submucosa the inflammation causes weakening and necrosis of arterial walls, leading to pseudoaneurysm formation followed by rupture and hemorrhage.
    • NSAIDs inhibit cyclooxygenase, leading to impaired mucosal defenses by decreasing mucosal prostaglandin synthesis.
    • During stress, there is acid hypersecretion; therefore, the breakdown of mucosal defenses leads to injury of the mucosa and subsequent bleeding.
    • Mucosal defects along with dilated and tortuous vessels in dieulafoy lesion put them at risk for rupture because of necrosis of the arterial wall from exposure to gastric acid.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inflammatory Bowel Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crohn's Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Ulcerative colitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on Region involved
 
 
 
 
 
 
 
 
 
Based on Severity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ileocolic Crohn's disease
 
Crohn's ileitis
 
Crohn's colitis
 
Stricturing disease
 
Penetrating disease
 
Inflammatory disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based on Region involved
 
 
 
 
 
 
 
Based on Severity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distal UC
 
 
 
Proximal UC
 
Mild
 
Moderate
 
Severe
 
Flumiant


 
 
 
 
 
 
 
 
 
 
 
 
 
 
A01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C02
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H01
 
 
 
 
 
 
 
 
 
 
H02
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I01
 
 
 
 
 
 
 
 
 
 
I02
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
J01
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Pathogenesis of Crohn's disease

  • Genetic component
  • Stress and environmental component
  • Microbial component
  • Inflammatory component

Genetic Component

Genes involved

  • NOD2/CARD15 gene
  • OCTN1 gene
  • DLG5 gene
  • TLR4 gene
Genes Chromosome Function Mutation
NOD2/CARD15 16 16q12.1 Encodes a scaffolding protein important for maintaining epithelial integrity Disrupts normal epithelial integrity
OCTN1 05 5q31 Ecodes an ion channel Alters the function of cation transporters and cell-to-cell signaling
DLG5 10 10q22.3 Interact additively with the NOD2/CARD15 gene Iincrease susceptibility to CD along with CARD15
TLR4 09 9q33.1 Lipopolysaccharide signaling, bacterial recognition, and subsequent immune response Altered immune response to pathogens and a subsequent increase in inflammation.

Stress and Environmental Component

  • Stress signals are perceived by the central nervous system (CNS), triggering the hypothalamic-pituitary-adrenal axis and the sympathetic-adrenal-medullary axis.
  • Neuroendocrine mediators released in response to stress not only modulate secretory, absorptive, and barrier functions in the gut but also increase the gut permeability.
  • Stress increases gut permeability along with other factors which inlude
    • Corticotropin-releasing factor
    • Autonomic nervous system
    • Enteric nervous system

Microbial Component

The possible mechanisms for a bacterial etiology in the development of CD include:

  • Initial immune response to a specific pathogen resulting in intestinal infection
  • Alterations in normal bacterial flora of the intestinal tract
  • Defective mucosal barrier and overwhelming exposure to resident bacteria and their antigens and endotoxins
  • Alterations to the intestinal immune response
Infectious Pathogens Implicated in Crohn’s Disease
  • Escherichia coli
  • Listeria monocytogenes
  • Yersinia enterocolitica
  • Mycobacterium avium subspecies paratuberculosis
  • Measles virus

Immune Component

  • Altered immune response:
    • An abnormal antibody response to an unspecified bacterial antigen is mainly responsible for inflammation in Crohn's disease.
    • The inflammatory response is believed to be triggered when elimination of specified microbial antigen was unsuccessful leading to altered immune response
    • Dysregulation of normal mucosal immune response results in failure of phagocytosis leading to antigen persistence.
    • Antigen persistance leads to antibodies production against all the normal gut flora.
    • Activation resulted in secretion of tumor necrosis factor-alpha (TNF-alpha) and subsequent epithelial changes.
  • Cytokine response:
    • The primary precipitating event in Crohn's disease is T-cell mediated immune response.
    • Activated T cells are responsible for the release of cytokines.
    • The production of inflammatory cytokines results in ulceration and increased intestinal permeability.
    • The characteristic granulomatous lesion seen in Crohn’s disease is evidence of a cell-mediated immune response.
    • The early lesions of Crohn's disease are characterized by elevations in interleukin-4 (IL-4) and decrease in IFN-gamma, a pattern more consistent with an overactive Th2 immune response.
    • Chronic lesions are associated with high levels of interleukin-2 (IL-2), interferon gamma (IFN-gamma), TNF-alpha, and interleukin-12 and -18 (IL-12 and IL-18) consistent with an Th1 immune response.
    • Tumor necrosis factor appears to play a significant role in the pathogenesis of CD.
      • TNF-alpha induces expression of adhesion factors that allow for inflammatory cells to infiltrate and activates macrophages to promote release of other pro-inflammatory mediators such as IFN-gamma.
      • Neutralization of TNF resulted in significant decrease in inflammation.
      • TNF-alpha concentrations in the stool can be used to monitor disease activity in both CD and UC.

Oxidative stress

  • Oxidative stress also plays a significant role in the pathogenesis of Crohn's disease.
  • Endogenous antioxidants such as superoxide dismutase (SOD), glutathione, and catalase normally counteract oxidative stress in the intestinal mucosa.
  • However, during the times of inflammation the demand for these antioxidants is increased resulting in an imbalance between oxidants and antioxidants, with subsequent mucosal damage.
  • Oxidative DNA damage can be measured from the amount of 8-hydroxy-deoxy-guanosine (8-OhdG) present in blood.
  • Levels of 8-OhdG are higher in patients with Crohn's disease.
  • Oxidative stress can also activate nuclear factor-kappaB (NF-kappaB) gene leading to release of TNF-alpha and interleukins involved in inflammation.

Other factors responsible for Pathogenesis of Crohn's disease

Platelet Abnormalities
  • Increased platelet count is a common feature of active Crohn’s disease and contributes to the increased incidence of thromboembolism seen in both CD and UC.
  • In addition to increased platelet count, CD is characterized by increased platelet activation in the mesenteric vessels.
  • Although platelet function has historically been considered to involve primarily blood clotting, there is considerable evidence for platelet involvement in inflammation.
  • Platelets from inflammatory bowel-diseased tissues have been found to express a number of inflammatory mediators, including CD40 L, a substance similar to tumor necrosis factor that directs platelets toward inflammation instead of aggregation.
  • A sequence of events has been postulated in which platelets trigger chemokine-mediated adhesion of white blood cells to the endothelium, causing leukocyte migration and subsequent focal inflammatory lesions.
Mitochondrial Dysfunction
  • TNF alpha enhances mitochondrial NF-kappa B expression, down-regulating mitochondrial RNA expression.
  • Resulting in impaired oxidative phosphorylation,with abnormalities in complexes III and IV.
Elevated Homocysteine
  • Vitamin B12 is essential for the metabolism of homo-cysteine to cysteine, taurine, sulfate, and glutathione.
  • Conditions that result in vit-B6 deficiency can lead to an increased levels of homo-cysteine levels.
  • Higher levels of homo-cysteine levels are associated with hypocoagulation states and subsequent thrombosis.
  • Therefore Crohn's patients are at risk for thrombo-embolism due to high homo-cysteine levels.

The Lactulose-Mannitol Test for Small Intestinal Hyperpermeability

  • Patient is made to swallows a solution of 5 g mannitol and 5 g lactulose.
  • Urine sample is collected for six hours.
  • Assay for total lactulose and mannitol
    • < 14% mannitol = carbohydrate malabsorption
    • >1% lactulose = disaccharide hyperpermeability
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
 
 
 
 
 
 
B02
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
C02
 
C03
 
C04
 
C05
 
C06
 
C07
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
C02
 
C03
 
C04
 
C05
 
C06
 
C07
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
B02


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
 
 
 
 
 
 
 
 
C04
 
 
 
 
 
 
 
 
 
C07
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
 
 
 
 
 
 
 
 
C04
 
 
 
 
 
 
 
 
 
C07
 
 
 
 
 
 
 


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C03
 
C04
 
C05
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C03
 
C04
 
C05